¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Ŭ"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 14 ÆäÀÌÁö: 13
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • monoclonal immunoglobulin disorders
    ´Ü(ÀÏ)Ŭ·Ð¼º ¸é¿ª±Û·ÎºÒ¸°ÀÌ»ó.
  • mononucleotidase
    ¸ð³ë´©Å¬·¹¿ÀƼ´ÙÁ¦, ¸ð³ë´©Å¬·¹¿ÀƼµåºÐÇØÈ¿¼Ò.
  • mononucleotide
    ¸ð³ë´©Å¬·¹¿ÀŸÀ̵å.
  • morbus herculeus ³ª
    Ç츣Ŭ¸®½ºº´(¡­Ü»).
  • musculamine
    ¹«½ºÅ¬¶ó¹Î.
  • myoclonic convulsion
    ¹Ì¿ÀŬ·Î´©½º°æ·Ã(¡­ÌâÕý).
  • myoclonic dementia
    ¹Ì¿ÀŬ·Î´©½ºÄ¡¸Å(¡­öÂ?).
  • myoclonic twitch
    ¹Ì¿ÀŬ·Î´©½º¾ç¿¬Ãà, °£´ë ¼º ±Ù°æ·Ã¾ç¿¬Ãà(¡­åÆÕýõê).
  • myoclonus epilepsy
    ¹Ì¿ÀŬ·Î´©½º°£Áú(¡­ÊÖòð).
  • naphthol ASD chloroacetate esterase
    ³ªÇÁÅç ASD Ŭ·Î·Î¾Æ¼¼Å×ÀÌÆ®¿¡½ºÅ×¶ó¾ÆÁ¦
  • neurofibromatosis
    ½Å°æ¼¶À¯Á¾Áõ(¡­ñø) ·ºÅ¬¸µÇÏ¿ìÁ¨º´(¡­Ü»)
  • neurofibromatosis
    ½Å°æ¼¶À¯Á¾Áõ,·ºÅ¬¸µÇÏ¿ìÁ¨º´
  • nicotinamide adenine nucleotide
    ´ÏÄÚÆ¾¾Æ¹Ìµå¾Æµ¥´Ñ´©Å¬·¹¿ÀƼµå
  • nocturnal myoclonus
    ¾ß°£¼º(¹Ì¿ÀŬ·Î´©½º)±Ù°æ·Ã.
  • nonejection systolic click
    ºñ±¸Ç÷¼º ¼öÃà±âŬ¸¯.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • V28.2
    Unspecified motorcycle rider injured in nontraffic accident
    ºñ±³Åë »ç°í¿¡¼­ ´ÙÄ£ »ó¼¼ºÒ¸íÀÇ ¸ðÅͽÎÀÌŬ ž½ÂÀÚ
  • V28.9
    Unspecified motorcycle rider injured in traffic accident
    ±³Åë»ç°í¿¡¼­ ´ÙÄ£ »ó¼¼ºÒ¸íÀÇ ¸ðÅͽÎÀÌŬ ž½ÂÀÚ
  • V29
    Motorcycle rider injured in other and unspecified transport accidents
    ±âŸ ¹× »ó¼¼ºÒ¸íÀÇ ¿î¼ö»ç°í¿¡¼­ ´ÙÄ£ ¸ðÅÍ»çÀÌŬ ž½ÂÀÚ
  • V29.2
    Unspecified motorcycle rider injured in collision with other and unspecified motor vehicles in nontraffic accident
    ºñ±³Åë»ç°í¿¡¼­ ±âŸ ¹× »ó¼¼ºÒ¸íÀÇ ÀÚµ¿Â÷¿Í Ãæµ¹·Î ´ÙÄ£ »ó¼¼ºÒ¸íÀÇ ¸ðÅÍ»çÀÌŬ ž½ÂÀÚ
  • V29.3
    Motor-cycle rider [any] injured in unspecified nontraffic accident
    »ó¼¼ºÒ¸íÀÇ ºñ±³Åë»ç°í¿¡¼­ ´ÙÄ£ [¸ðµç] ¸ðÅÍ»çÀÌŬ ž½ÂÀÚ
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
Ŭ·ÎƾÁ¤ - »õâ
Çѱ¹¿þÀÏÁîÁ¦¾à(ÁÖ)
A15204471 Clarithromycin
Àü¹®ÀǾàǰ | »èÁ¦
Ŭ¶ó·Î½ÅÁ¤ - »õâ
Á¦À̾ËÇÇ
A09003711 Clarithromycin
Àü¹®ÀǾàǰ | ±Þ¿©
Ŭ¶óÁøÁ¤ - »õâ
Çѱ¹À¯´Ï¿ÂÁ¦¾à
A12202501 Clarithromycin
Àü¹®ÀǾàǰ | ±Þ¿©
Ŭ·¡½ÃµåÁ¤ - »õâ
SKÄɹÌÄ®
A18901981 Clarithromycin
Àü¹®ÀǾàǰ | »èÁ¦
Ŭ·º¼¼Æ¾°ÇÁ¶½Ã·´125mg/5ml - »õâ
ÀÌÅØ½ºÁ¦¾à
A18752881 Clarithromycin
Àü¹®ÀǾàǰ | ±Þ¿©
Ŭ·Î´Ð½ºÁ¤250mg - »õâ
¾¾Æ®¸®
A13851501 Clonixin Lysinate
ÀϹÝÀǾàǰ | ±Þ¿©
Ŭ·Îº£Å¸Á¨Å©¸² - »õâ
´ºÁ¨ÆÊ
A13353991 Clobetasone Butyrate
Àü¹®ÀǾàǰ | ±Þ¿©
Ŭ¶ó¸àƾÁ¤ - »õâ
±âÈ­Á¦¾à
A14751411 Amoxicillin sodium, Potassium clavulanate
Àü¹®ÀǾàǰ | »èÁ¦
Ŭ·¡·Î½ÅÁ¤ - »õâ
¹Ì·¡Á¦¾à
A20602631 Clarithromycin
Àü¹®ÀǾàǰ | »èÁ¦
Ŭ¸®ÁöµåÁ¤ - »õâ
À¯³ªÀÌÆ¼µåÀÎÅÍÆÊ
A73450181 Gliclazide
Àü¹®ÀǾàǰ | ±Þ¿©
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • cloque
    Ŭ·ÎÄÉ(¹«´Ì µîÀÌ µµµå¶óÁø Á÷¹°)
  • close shot
    Á¢»ç;Ŭ·ÎÁî¾÷
  • close-up
    ´ë»ç;Ŭ·ÎÁî¾÷;±ÙÁ¢»çÁø;»ó¼¼ÇÑ °üÂû(°Ë»ç,¹¦»ç);(ÀÏÀÇ)Áø»ó
  • closed shop
    Ŭ·Î½ºµå¼ó;³ëµ¿Á¶ÇÕ¿ø¸¸À» °í¿ëÇÏ´Â »ç¾÷Àå;ÄÄÇ»ÅÍ »ç¿ë ¹æ¹ýÀÇ Çϳª;ÇÁ·Î±×·¥ ÀÛ¼º ¹× Á¶ÀÛ µîÀ» Àü¹® ´ã´çÀÚ°¡ ÇÏ´Â ¹æ½Ä
  • clostridium
    Ŭ·Î½ºÆ®¸®µã¼ÓÀÇ ¼¼±Õ
  • cloth
    õ;ÇÇ·ú;¿Ê°¨;Çë°Ò;½ÄŹº¸;ÇàÁÖ;°É·¹;¸ðÁ÷¹°;³ª»ç;Ŭ·Î½º;Çë°ÒÇ¥Áö;¹üÆ÷;µÀ;°ËÀº ¼ºÁ÷º¹;¼ºÁ÷;¼ºÁ÷ÀÚµé
  • cloth binding
    (Ã¥ÀÇ)Ŭ·Î½ºÇ¥Áö(Á¦º»);Ŭ·Î½ºÀåÁ¤(º»)
  • clothback
    Ŭ·Î½ºÀåÁ¤º»
  • clothbound
    (Ã¥ÀÌ)Ŭ·Î½ºÀåÁ¤ÀÇ
  • clover
    Ŭ·Î¹ö;Å䳢Ǯ(Äá°ú ½Ä¹°)
  • cloverleaf
    (³×ÀÙŬ·Î¹öÇüÀÇ)ÀÔü±³Â÷·Î;³× À٠Ŭ·Î¹ö Çü(¸ð¾ç)ÀÇ
  • cloxacillin
    Ŭ·Ï¼­½Ç¸°(ÇÕ¼ºÆä´Ï½Ç¸°ÀÇ ÀÏÁ¾)
  • club
    °ïºÀ;Ŭ·´;Ÿ±¸ºÀ;°øºÀÇüÀÇ ±¸Á¶(±â°ü);Ŭ·´½Ç;Ŭ·´È¸°ü;Ŭ·´ÀÇ ºý;°ïºÀÀ¸·Î ¶§¸®´Ù(È¥³»ÁÖ´Ù);(ÃÑ µîÀ»)°ïºÀ ´ë½ÅÀ¸·Î ¾²´Ù;(µ·.»ý°¢ µîÀ»)Çù·ÂÇÏ¿© ¸ðÀ¸´Ù;(ÁöÃâµîÀ»)ºÐ´ãÇÏ´Ù;(»ç¶÷À»)¸ð¾Æ¼­ Ŭ·´À» ¸¸µé´Ù;...À» ÇÕµ¿(°áÇÕ)½ÃŰ´Ù;Ŭ·´À» Á¶Á÷ÇÏ´Ù;(°øµ¿ ¸ñÀû¿¡)Çù·ÂÇÏ´Ù
  • club sandwich
    Ŭ·´»÷µåÀ§Ä¡(¼¼°ãÀÇ Å佺Ʈ¿¡ °í±â.¾ß並 ³¢¿ö ³ÖÀº °Í)
  • clubbable
    Ŭ·´È¸¿ø¿¡ ÀûÇÕÇÑ;»ç±³ÀûÀÎ;clubbability()
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á